AllCells News and Events

News & Events

Stay current with AllCells news and events! Check back often to read the latest press releases, stay apprised of company announcements, and learn about upcoming events. AllCells participates in several regional and national shows, annual meetings and conferences throughout the year - these events are great opportunities for current and future customers to interact with the AllCells team. AllCells will be present at the following events and look forward to meeting you.


Addition of Eurofins Donor and Product Testing

Alameda, CA – August 31, 2021. AllCells is committed to providing the best-in-class third-party services complementary to our high-quality products. Due to the increasing demand for extended donor testing, we have added Eurofins Donor and Product Testing as an approved supplier for serology and sterility testing. The addition of Eurofins Donor and Product Testing will […]


Maintain Flexibility in your Workflow without Compromising Quality – Cryopreserved Leukopaks

Alameda, CA – September 15, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today the addition of Cryopreserved Leukopaks to their extensive product portfolio. Get the quality of fresh cells with the convenience of cryopreserved cells with this new product offering. Benefits include: High-Quality […]


AllCells Announces Expanded Product Portfolio, Guaranteed Cell-Count Leukopaks

Alameda, CA – August 13, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today that it has expanded its portfolio of primary cells with the launch of the Guaranteed Cell-count Leukopaks.  AllCells is committed to the success of your workflow and removing donor-to-donor variability […]


Product Update Notification - Leukopaks Shipping at 2-8°C

Dear Valued Customer, As part of our commitment to quality, we are continuously improving our processes, products, and logistics. To this end, we wanted to notify our Leukopak customers of a change that will contribute to the improved quality of our Whole LP family of products. In support of many of our Clinical Grade LP […]


AllCells is Considered an Essential Business - Delivering at Partial Capacity

Dear Valued Client, Providing our customers with high quality materials to produce the next generation of cell and gene therapies while providing world-class partnership and support is at the heart of our business. With that in mind, I would like to share that AllCells is categorized as an essential business and will be providing products […]


Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells

February 7, 2019 Walkersville, MD (USA) / Basel (CH) – Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. This partnership expands Lonza’s broad offering of hematopoietic cell lines and enables cell biologists to easily access a wide selection of […]


AllCells Announces New Faster Delivery Times

May 15, 2018 ALAMEDA, Calif.–(BUSINESS WIRE)–AllCells, LLC, the leading supplier of blood-derived cells and services for immuno- and cell therapy development, announced today that it has changed its business model to respond more quickly to research needs, delivering fresh products in as little as three days. AllCells, since its founding 20 years ago by research […]


Upcoming Events

Meeting on the Mesa

October 12 - October 14, 2021. Carlsbad, California

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.


OCTS 2021

November 16 - November 18, 2021. Boston, Massachusetts

The Onco Cell Therapy Summit (OCTS), November 16 - 18, Boston USA, brings the industry together to share novel research, manufacturing techniques, and regulatory best practice. Each session of OCTS 2021 is dedicated to the process of translating R&D into commercially viable oncological therapies.


Phacilitate 2022

January 25 - January 28, 2022. Miami, Florida

Advanced Therapies Week 2022 (previously Phacilitate Leaders World) will be taking place in January 2022 in Miami. The show will bring together the entire ecosystem of the advanced therapies industry from all corners of the globe. Known as the event for the industry; at Advanced Therapies Week you will have the opportunity to explore, share, challenge and discuss the latest industry updates and discover new innovative technologies in Cell & Gene Therapy, Immuno-oncology and Tissue Engineering.


Have a question? Let’s chat.